首页> 外文学位 >HIV-1-derived lentiviral vectors pseudotyped with envelope glycoproteins derived from Ross River virus and Semliki Forest virus.
【24h】

HIV-1-derived lentiviral vectors pseudotyped with envelope glycoproteins derived from Ross River virus and Semliki Forest virus.

机译:用源自罗斯河病毒和塞姆利基森林病毒的包膜糖蛋白假型化HIV-1衍生的慢病毒载体。

获取原文
获取原文并翻译 | 示例

摘要

To improve gene transfer, HIV-1-derived lentiviral vectors can be "re-targeted" to infect different ranges of target cells by incorporating glycoproteins originating from foreign viruses in their envelope shell---a process named pseudotyping. The commonly used vesicular stomatitis virus glycoprotein (VSV-G) confers a broad host range upon the lentiviral vector. However, VSV-G suffers from a number of drawbacks, such as cell toxicity, that poses limitations on its use in gene therapy protocols. This dissertation wanted to investigate the potential of less toxic glycoproteins derived from Ross River virus (RRV) and Semliki Forest virus (SFV) for pseudotyping lentiviral vectors. RRV and SFV glycoproteins incorporated into lentiviral vectors, and formed infectious pseudotypes that could be efficiently concentrated by ultracentrifugation and were able to infect a wide range of target cells, similar to VSV-G pseudotypes. A systematic analysis revealed that lentiviral vectors incorporate RRV glycoproteins with a comparable efficiency to VSV-G. Both pseudotypes have comparable physical titers, but infectious titers with the RRV pseudotype are lower than with VSV-G. Incorporation of SFV glycoproteins into lentiviral vector is less efficient, leading to decreased physical and infectious titers. Transduction with VSV-G, RRV, and SFV pseudotypes in adherent cell lines can be significantly increased by using recombinant fibronectin and polybrene in combination, Together, the findings suggest that RRV glycoproteins may be an attractive alternative to VSV-G for pseudotyping lentiviral vectors. Further experiments showed a particular resistance of most non-adherent hematopoietic cells to infection with the RRV pseudotype, but not to the VSV-G-pseudotype. Exceptions were erythroleukemia-derived cells, and differentiated macrophage-like cells that were moderately permissive for infection with RRV pseudotype. Enzymatic digestion of cell surface proteins, but not other molecules, had an inhibitory effect on infection with RRV pseudotypes. The data suggest that efficient transduction with RRV-pseudotyped lentiviral vectors is mainly dependent on the cell type and the degree of cellular differentiation. In addition, cell surface proteins may play an important role in the viral entry pathway of RRV. These findings will be important in elucidating the mechanism of RRV uptake and infection and may prove useful in designing strategies for selective transduction of target cell populations.
机译:为了改善基因转移,可以将HIV-1衍生的慢病毒载体“重新靶向”,通过将外源病毒的糖蛋白掺入其包膜外壳中来感染不同范围的靶细胞,这一过程称为假型化。常用的水泡性口腔炎病毒糖蛋白(VSV-G)在慢病毒载体上具有广泛的宿主范围。然而,VSV-G具有许多缺点,例如细胞毒性,这限制了其在基因治疗方案中的使用。本文旨在研究罗斯河病毒(RRV)和塞姆利基森林病毒(SFV)毒性较小的糖蛋白在慢病毒载体假型化中的潜力。将RRV和SFV糖蛋白掺入慢病毒载体中,并形成可通过超速离心有效浓缩并能够感染多种靶细胞的感染性假型,类似于VSV-G假型。系统分析表明,慢病毒载体掺入RRV糖蛋白的效率与VSV-G相当。两种假型具有相似的物理滴度,但具有RRV假型的感染性滴度低于VSV-G。 SFV糖蛋白掺入慢病毒载体的效率较低,导致物理和感染滴度降低。通过结合使用重组纤连蛋白和聚丙烯,可以显着增加贴壁细胞系中VSV-G,RRV和SFV假型的转导。总之,研究结果表明RRV糖蛋白可能是VSV-G假冒慢病毒载体的诱人替代品。进一步的实验表明,大多数非粘附性造血细胞对RRV假型的感染具有特定的抵抗力,但对VSV-G假型的感染没有抵抗力。红细胞白血病衍生的细胞和分化的巨噬细胞样细胞除外,它们对于RRV假型的感染具有中等程度的允许性。酶消化细胞表面蛋白,而不是其他分子,对RRV假型感染具有抑制作用。数据表明,使用RRV假型慢病毒载体的有效转导主要取决于细胞类型和细胞分化程度。另外,细胞表面蛋白可能在RRV的病毒进入途径中起重要作用。这些发现对阐明RRV摄取和感染的机制很重要,并可能在设计选择性转导靶细胞群的策略中有用。

著录项

  • 作者

    Kahl, Christoph Adrian.;

  • 作者单位

    Indiana University.;

  • 授予单位 Indiana University.;
  • 学科 Biology Microbiology.; Biology Genetics.
  • 学位 Ph.D.
  • 年度 2003
  • 页码 144 p.
  • 总页数 144
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 微生物学;遗传学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号